Piper Sandler raised the firm’s price target on Tactile Systems (TCMD) to $20 from $14 and keeps a Neutral rating on the shares. The firm notes the company posted Q3 top-line results that beat estimates, driven by good performance in both the Lymphedema and AffloVest businesses. Tactile increased its full year 2025 guidance by $6.5M at the midpoint to $317M-$321M as strength in the AffloVest business is expected to continue and as the lymphedema business is benefiting from increased productivity from a larger sales force. However, Piper wrestles with some of the visibility into the ongoing trends in this business after two consecutive guide downs to start the year.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TCMD:
- Tactile Systems price target raised to $32 from $23.50 at Lake Street
- Strong Buy Recommendation for Tactile Systems Technology: Promising Growth and Strategic Initiatives Drive Confidence
- Tactile Systems upgraded to Buy from Neutral at BTIG
- Tactile Systems Technology Reports Strong Q3 2025 Results
- Tactile Systems reports Q3 EPS 36c, consensus 20c